Document Detail

Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience.
MedLine Citation:
PMID:  12582408     Owner:  NLM     Status:  MEDLINE    
A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration. Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days. Allergic contact dermatitis to doxepin cream should be considered in patients whose condition fails to improve or worsens with doxepin use.
Renan A Bonnel; Lois La Grenade; Claudia B Karwoski; Julie G Beitz
Related Documents :
18086998 - A 3-year causative study of pompholyx in 120 patients.
20161868 - Low chromate diet in dermatology.
2882598 - Circulating tachykinins (substance p, neurokinin a, neuropeptide k) and the carcinoid f...
3411388 - Atopic dermatitis: clinical relevance of food hypersensitivity reactions.
15668678 - Dietary fiber intake by american preschoolers is associated with more nutrient-dense di...
11830278 - Chronic intraparaventricular nuclear administration of orexin a in male rats does not a...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  48     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-12     Completed Date:  2003-03-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  294-6     Citation Subset:  IM    
Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, Room 15B-23, HFD-430, Rockville, MD 20857, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Antipruritics / administration & dosage,  adverse effects*
Dermatitis, Allergic Contact / etiology*
Doxepin / administration & dosage,  adverse effects*
Middle Aged
Product Surveillance, Postmarketing*
Reg. No./Substance:
0/Antipruritics; 1668-19-5/Doxepin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rickettsialpox in a patient with HIV infection.
Next Document:  Oral lichen planus: an update.